Termination of Equity Distribution Agreement between PLx Pharma Inc. and JMP Securities LLC
PLx Pharma Inc. and JMP Securities LLC have agreed to terminate their Equity Distribution Agreement, originally dated March 25, 2019. This termination is effective as of March 2, 2021, and serves as official notice to JMP Securities LLC that the agreement is ended. Both parties confirm that this document represents their full understanding regarding the termination, and any changes must be made in writing and signed by both parties. The agreement is governed by Delaware law.
Exhibit 10.1
TERMINATION OF EQUITY DISTRIBUTION AGREEMENT
This Termination of Equity Distribution Agreement (this “Agreement”), dated as of March 2, 2021, is made by and between PLx Pharma Inc. (the “Company”), and JMP Securities LLC (“JMP,” and, together with the Company, each a “Party” and collectively, the “Parties”).
WHEREAS, JMP and the Company are party to that certain Equity Distribution Agreement, dated as of March 25, 2019 (the “Equity Distribution Agreement”), pursuant to which JMP acted as a placement agent on behalf of the Company; and
WHEREAS, the Company desires to terminate the Equity Distribution Agreement in its entirety pursuant to Section 12(b) of the Equity Distribution Agreement.
NOW THEREFORE, in consideration of the mutual promises made herein and other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties hereby agree as follows:
1. Termination. Pursuant to Section 12(b) of the Equity Distribution Agreement, this Agreement shall act as notice to JMP of the Company’s termination of the Equity Distribution Agreement.
2. Entire Agreement. This Agreement constitutes the full and complete understanding and agreement between the Parties with regard to the subject matter hereof. This Agreement may not be amended, waived, discharged or terminated other than by a written instrument signed by both Parties hereto.
3. Counterparts. This Agreement may be executed in counterparts, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned Parties.
4. Governing Law. This Agreement will be governed by, and construed in accordance with, the laws of the State of Delaware applicable to contracts executed in and to be performed entirely within that State, without reference to conflicts of law provisions.
[Signature Page Follows]
IN WITNESS WHEREOF, the Parties have executed this Agreement as of date first above written.
PLX PHARMA INC. | |||
By: | /s/ Natasha Giordano | ||
Name: | Natasha Giordano | ||
Title: | President & Chief Executive Officer |
ACCEPTED AND AGREED: JMP SECURITIES LLC | |||
By: | /s/ Walter Conroy | ||
Name: | Walter Conroy | ||
Title: | Chief Legal Officer and Secretary |